Colorectal Cancer (CRC) Terminated Phase 2 Trials for Cetuximab (DB00002)

Back to Colorectal Cancer (CRC)

Also known as: Malignant Neoplasm of Colorectum / CRC, Colorectal Cancer / Colorectal Cancer / Cancer, Colorectal / CRC (Colorectal Cancer) / Colorectal, Cancer / Colo-rectal Cancer / Colorectal Cancers / A. Colorectal Cancer / Cancer Colorectal / Gastrointestinal Cancers - Colorectal / CRC / CRCS / Malignant colorectal neoplasm / Malignant neoplasm of cecum and/or colon and/or rectum / Malignant neoplasm of caecum and/or colon and/or rectum / Malignant neoplasm of cecum and/or colon and/or rectum (disorder) / Malignant neoplasm of large intestine / Malignant tumor of large intestine / Malignant tumour of large intestine / Malignant neoplasm of large intestine (disorder) / Malignant neoplasm of colon, unspecified / Malignant large intestinal neoplasm NOS / Cancer of large intestine / Malignant neoplasm of large intestine, NOS / Cancer of large bowel / CA - Cancer of large bowel / Colorectal neoplasms malignant / Malignant neoplasm of colon and/or rectum (disorder) / Large intestine carcinoma / Colorectal carcinoma / Colorectal cancer NOS

Indication	Status	Phase
DBCOND0031867 (Colorectal Cancer (CRC))	Terminated	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT05619172	A Study of Nanrilkefusp Alfa (SOT101) in Combination With Cetuximab to Evaluate the Efficacy and Safety in Patients With Colorectal Cancer	Treatment	Cetuximab (DB00002) Nanrilkefusp alfa (DB17480)
NCT04853043	Cetuximab in Third Line for Mutant APC, TP53 and RAS Patients With Refractory Metastatic Colorectal Cancer	Treatment	Cetuximab (DB00002)
NCT00766142	Chemotherapy and Cetuximab in Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer	Treatment	Cetuximab (DB00002) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00755118	Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc	Treatment	Bevacizumab (DB00112) Cetuximab (DB00002) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00755534	Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC	Treatment	Capecitabine (DB01101) Cetuximab (DB00002) Irinotecan (DB00762) Oxaliplatin (DB00526)
NCT05576896	Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory	Treatment	Cetuximab (DB00002) Encorafenib (DB11718) Hydroxychloroquine (DB01611) Panitumumab (DB01269)
NCT00681876	Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer	Treatment	Bevacizumab (DB00112) Cetuximab (DB00002) Irinotecan (DB00762)
NCT00537823	Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement	Treatment	Bevacizumab (DB00112) Cetuximab (DB00002) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00271011	A Study of Mitomycin C, Irinotecan, and Cetuximab	Treatment	Cetuximab (DB00002) Irinotecan (DB00762) Mitomycin (DB00305)
NCT01004159	Cetuximab Plus Irinotecan in Colorectal Cancer Patients Who Progressed After Failure With Cetuximab Plus Irinotecan	Treatment	Cetuximab (DB00002) Irinotecan (DB00762)
NCT00251186	First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients	Treatment	Capecitabine (DB01101) Cetuximab (DB00002)
NCT01032291	A Study to Assess the Efficacy and Safety of Lenalidomide in Combination With Cetuximab in Pre-treated Patients With KRAS Mutant Colorectal Cancer	Treatment	Cetuximab (DB00002) Lenalidomide (DB00480)
NCT00538291	Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment	Treatment	Capecitabine (DB01101) Cetuximab (DB00002)
NCT00541112	Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery	Treatment	Capecitabine (DB01101) Cetuximab (DB00002) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT01060423	TACE With Irinotecan Drug-eluting Beads and Intravenous (IV) Cetuximab in Refractory Colorectal Cancer	Treatment	Cetuximab (DB00002) Irinotecan (DB00762)